Status:
UNKNOWN
Comparison Between LDCT With DL Recontruction and Standard Dose CT
Lead Sponsor:
Seoul National University Hospital
Conditions:
Liver Metastases
Eligibility:
All Genders
20-85 years
Brief Summary
This prospective study aims to perform intra-individual comparison of the image quality between low dose liver CT with deep learning reconstruction and standard dose liver CT with iterative reconstruc...
Eligibility Criteria
Inclusion
- patients with underlying malignancy and suspicion of liver metastasis
- patients with known liver metastasis and on follow-up
- AND scheduled for contrast enhanced abdomen CT
- signed informed consent
Exclusion
- absolute or relative contra-indication for contrast-enhanced CT
- diffuse infiltrative liver lesion or multiple (\> 10) metastases
Key Trial Info
Start Date :
June 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT05324046
Start Date
June 2 2022
End Date
June 30 2024
Last Update
August 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea
2
Ulsan University Hospital
Ulsan, South Korea, 44033